Development of technologies that accelerate the immune response to biodefense vaccines

Ended Definitive Contract Awarded Last action

Contract number
HHSN272201200018C
Awardee
Awarding agency
Obligated
$18,446,872

Award facts

Opportunity
Contract value 100% obligated
$18,446,871.69 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC
AN13 Health R&D Services; Health Care Services; Experimental Development
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Denmark

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00011 -$4,849,337
Funding Only Action 10 $146,246
Supplemental Agreement for work within scope 9 $0
Supplemental Agreement for work within scope 8 $0
Exercise an Option 7 $15,129,088
Supplemental Agreement for work within scope 6 $0
Other Administrative Action 5 $0
Exercise an Option 4 $3,593,334
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 $0
Original award $4,427,541
Show all 12

Quick answers

Who was awarded contract HHSN272201200018C?

HHSN272201200018C was awarded to Bavarian Nordic A / S by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 11, 2012.

How much is contract HHSN272201200018C worth?

The government has obligated $18,446,872 on HHSN272201200018C.

Was contract HHSN272201200018C competed?

The extent of competition for HHSN272201200018C was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award